Mosanna Therapeutics

Developer of small molecule therapeutics for sleep apnea

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 2022 groups4 employees language mosanna.com

Innovation

2 patent families — focus: Human necessities; filing pace active. Cited 24 times.

YearFilings
20252

Investor mix

8 investors on record; lead investors include Forty51 Ventures, Supermoon Capital, HTGF, EQT.

Investor typeCountShare
Venture capital788%
Private equity113%
Coming soon